<html>
<head>
<style><!--
.hmmessage P
{
margin:0px;
padding:0px
}
body.hmmessage
{
font-size: 10pt;
font-family:Tahoma
}
--></style></head>
<body class='hmmessage'><div dir='ltr'>
<pre><br>MIE 2012 workshop<br> <br><a href="http://natalia.grabar.perso.sfr.fr/CMPV/" target="_blank">http://natalia.grabar.perso.sfr.fr/CMPV/</a><br> <br>Computational Methods in Pharmacovigilance<br> <br>Pharmacovigilance is the activity related to the collection, analysis and<br>prevention of adverse drug reactions induced by drugs or biologics. This<br>activity plays the fundamental role in monitoring the patient safety<br>during their healthcare process and beyond it. Although this activity<br>relies on a strong surveillance tradition within the<br>pharmacoepidemiological area, some limitations appear and generate<br>uncomfortable cases widely covered by media (such as those related to<br>Mediator, VIOXX etc). First of all, these are due to the ever increasing<br>amount of the data to collect and to process, and also to the recording<br>and storage of these data in the digital form. Hence, the computational<br>methods may provide with useful and intelligent solutions for
a more rapid<br>and systematic management of these data.<br> <br>In this workshop, we favour the submission of various and novel<br>experiments related to the computational methods in pharmacovigilance and<br>describing different aspects of the pharmacovigilance process, as<br>performed by acamedic researchers, institutional or industrial people:<br>– Collection of the pharmacovigilance data: traditionnally, the<br>pharmacovigilance cases are narrative documents spontaneously submitted by<br>medical staff, by pharmacists and sometimes even by patients themselves.<br>The actual concern is that the collection of these cases is far from being<br>complete. In this situation, special efforts are oriented on the<br>computational assistance when collecting and gathering the<br>pharmacovigilance cases from the raw textual sources. Moreover, the<br>reporting standards and frames are also addressed by the researchers.<br>– Analysis of the pharmacovigilance data: this step relies on t
he encoding<br>of the cases with the dedicated terminologies and then on the semantic and<br>statistical analysis of these cases. The concerns are related to various<br>aspects, such as (1) the semantic correspondence between the cases and the<br>terms; (2) the methods for the encoding of the cases; (3) the managing of<br>semantic ambiguity and relatedness between the terms; (4) exploitation of<br>the SMQs and of the related data; (5) terminological and ontological<br>representation within the dedicated terminologies; (6) computational<br>methods for the signal detection, etc.<br>– Prevention of adverse drug reactions: the prevention step aims at<br>facilitating the exchange of information through the well established<br>national and international networks. It manages specifically the<br>grave adverse drug reactions and the guidelines which help countries to<br>strengthen the pharmaceutical politics and decisions.<br>– etc.<br> <br>The objective of this workshop is
to gather people working on various<br>aspects of the pharmacovigilance. Experiments performed within academic,<br>instritutional or industrial contexts are welcome.<br> <br> <br>SUBMISSIONS:<br> <br>The authors are invited to prepare 5 page submissions with the respect of<br>the MIE conference style:<br>- <a href="http://www.mie2012.it/documents/fullpaper.dot" target="_blank">http://www.mie2012.it/documents/fullpaper.dot</a><br>- <a href="http://www.mie2012.it/documents/instruction.pdf" target="_blank">http://www.mie2012.it/documents/instruction.pdf</a><br> <br>For any questions, please contact natalia.grabar@univ-lille3.fr<br> <br> <br>IMPORTANT DATES:<br> <br>May 1, 2012: 1st call for submissions<br>June 15, 2012: Paper due date<br>July 10, 2012: Notifications to Authors<br>July 25, 2012: Camera-ready version<br>Aug 28, 2012: MIE conference and workshop<br> <br> <br>SCIENTIFIC COMMITTEE:<br> <br>- Ismaïl Ahmed, Equipe Biostatistique, CESP, UMRS 1018 Inserm, Université<br
>Paris Sud, France<br>- Andrew Bate, Visiting Professor, Department of Information Systems and<br>Computing, Computing and Mathematics, Brunel University, London, UK,<br>Adjunct Associate Professor of Medicine, Division of Clinical Pharmacology<br>NYU School of Medicine, New York, USA and faculty of the NYU Center for<br>Health Informatics and Bioinformatics, USA<br>- Kevin Cohen, University of Colorado School of Medicine and University of<br>Colorado at Boulder, USA<br>- Mélanie Courot, BC Cancer Agency, Vancouver, Canada<br>- Reinhard Fescharek, Behring Inc., Germany<br>- Thierry Hamon, LIM&BIO, Université Paris 13, France<br>- Mikaela Keller, CNRS LIFL UMR8022, Mostrare INRIA, Université Lille 1<br>and 3, France<br>- Halil Kilicoglu, National Library of Medicine, NIH, USA<br>- Niklas Noren, Uppsala Monitoring Centre, WHO Collaborating Centre for<br>International Drug Monitoring, Uppsala, Sweden<br>- Patrick Ruch, University of Applied Sciences, Geneva, Switzerland<br>
- Ozlem Uzuner, University at Albany, SUNY, USA<br>- ...<br> <br> <br>ORGANIZERS:<br> <br>Marie Dupuch, CNRS STL UMR 8163, U Lille 1 et 3, France<br>Frantz Thiessard, ISPED, U Bordeaux Segalen, France<br>Natalia Grabar, CNRS STL UMR 8163, U Lille 1 et 3, France<br>Jim Slattery, European Medicines Agency, London, UK</pre> </div></body>
</html>